PT2493508T - Composições farmacêuticas transdérmicas compreendendo agentes activos - Google Patents
Composições farmacêuticas transdérmicas compreendendo agentes activosInfo
- Publication number
- PT2493508T PT2493508T PT10768983T PT10768983T PT2493508T PT 2493508 T PT2493508 T PT 2493508T PT 10768983 T PT10768983 T PT 10768983T PT 10768983 T PT10768983 T PT 10768983T PT 2493508 T PT2493508 T PT 2493508T
- Authority
- PT
- Portugal
- Prior art keywords
- pharmaceutical compositions
- active agents
- transdermal pharmaceutical
- transdermal
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25524109P | 2009-10-27 | 2009-10-27 | |
| EP09178762 | 2009-12-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT2493508T true PT2493508T (pt) | 2018-10-09 |
Family
ID=42102488
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT181636598T PT3360575T (pt) | 2009-10-27 | 2010-10-27 | Composições farmacêuticas transdérmicas compreendendo agentes ativos |
| PT10768983T PT2493508T (pt) | 2009-10-27 | 2010-10-27 | Composições farmacêuticas transdérmicas compreendendo agentes activos |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT181636598T PT3360575T (pt) | 2009-10-27 | 2010-10-27 | Composições farmacêuticas transdérmicas compreendendo agentes ativos |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US10080760B2 (ja) |
| EP (2) | EP2493508B1 (ja) |
| JP (1) | JP5727494B2 (ja) |
| CN (1) | CN102686240B (ja) |
| AU (1) | AU2010311523B2 (ja) |
| BR (1) | BR112012010083B8 (ja) |
| CA (1) | CA2778689C (ja) |
| CY (1) | CY1120888T1 (ja) |
| DK (2) | DK3360575T3 (ja) |
| ES (2) | ES2685313T3 (ja) |
| FI (1) | FI3360575T3 (ja) |
| HR (2) | HRP20230482T1 (ja) |
| HU (2) | HUE062026T2 (ja) |
| IL (1) | IL219236A (ja) |
| LT (2) | LT3360575T (ja) |
| PL (2) | PL2493508T3 (ja) |
| PT (2) | PT3360575T (ja) |
| RS (2) | RS57596B1 (ja) |
| RU (2) | RU2639087C2 (ja) |
| SI (2) | SI2493508T1 (ja) |
| TR (1) | TR201811600T4 (ja) |
| WO (1) | WO2011051354A2 (ja) |
| ZA (1) | ZA201202855B (ja) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2147674A1 (en) * | 2008-07-24 | 2010-01-27 | Besins Healthcare | Transdermal pharmaceutical compositions comprising danazol |
| US10080760B2 (en) | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
| US20120004204A1 (en) * | 2010-07-02 | 2012-01-05 | Biosante Pharmaceuticals, Inc. | Methods for treating sexual dysfunction while decreasing cardiovascular risk |
| ES2885523T3 (es) | 2011-11-23 | 2021-12-14 | Therapeuticsmd Inc | Formulaciones y terapias de reposición hormonal de combinación naturales |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| RU2592370C9 (ru) * | 2014-04-24 | 2016-08-27 | Иван Иванович Дедов | Средство на основе дегидроэпиандростерона, способ его применения |
| AU2015264003A1 (en) | 2014-05-22 | 2016-11-17 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| WO2016018993A1 (en) | 2014-07-29 | 2016-02-04 | Therapeuticsmd, Inc. | Transdermal cream |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
| WO2017173071A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical composition |
| EP3370178A3 (en) | 2017-03-03 | 2018-12-19 | Tata Consultancy Services Limited | Method and system for in silico testing of actives on human skin |
| RU2751037C1 (ru) * | 2020-04-03 | 2021-07-07 | Богдан Иванович Асатуров | Фармацевтическая композиция на основе аутобиокомпонентов мочи человека для трансдермального применения с лечебной или косметической целью |
| CN111803469B (zh) * | 2020-07-15 | 2022-08-12 | 浙江海阁堂医药有限公司 | 一种含雌二醇透皮吸收缓释贴片及其制备方法 |
| CN113730339B (zh) * | 2021-09-17 | 2023-08-22 | 中国药科大学 | 一种黄体酮缓释组合物及其应用 |
| CN117545474A (zh) * | 2021-11-08 | 2024-02-09 | 李维庸 | 一种用于向患者递送药物的透皮给药系统 |
Family Cites Families (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1106455B (de) | 1959-05-29 | 1961-05-10 | Upjohn Co | Salbengrundlage |
| FR2518879A1 (fr) | 1981-12-30 | 1983-07-01 | Besins Jean | Medicament a base d'oestradiol pour le traitement de la pathologie menopausique |
| US4906169A (en) | 1986-12-29 | 1990-03-06 | Rutgers, The State University Of New Jersey | Transdermal estrogen/progestin dosage unit, system and process |
| JPH0798935B2 (ja) | 1987-11-25 | 1995-10-25 | 有限会社野々川商事 | 品質劣化防止剤 |
| CA2000401C (en) | 1988-10-11 | 1996-05-28 | Masato Azuma | Percutaneous pharmaceutical preparation |
| US5332577A (en) | 1988-12-27 | 1994-07-26 | Dermamed | Transdermal administration to humans and animals |
| US5232703A (en) | 1989-07-21 | 1993-08-03 | Izhak Blank | Estradiol compositions and methods for topical application |
| EP0409383B1 (en) | 1989-07-21 | 1994-04-06 | Izhak Blank | Estradiol compositions and methods for topical applications |
| WO1992007590A1 (en) | 1990-10-29 | 1992-05-14 | Alza Corporation | Transdermal contraceptive formulations, methods and devices |
| DE4227989A1 (de) | 1992-08-21 | 1994-06-09 | Schering Ag | Mittel zur transdermalen Applikation enthaltend 3-Keto-desogestrel |
| WO1995017896A1 (fr) | 1993-12-27 | 1995-07-06 | Akzo Nobel N.V. | Preparation pour absorption par voie percutanee |
| CN1106259A (zh) | 1994-02-05 | 1995-08-09 | 日东制药株式会社 | 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂 |
| FR2732223B1 (fr) * | 1995-03-30 | 1997-06-13 | Sanofi Sa | Composition pharmaceutique pour administration transdermique |
| US5902603A (en) * | 1995-09-14 | 1999-05-11 | Cygnus, Inc. | Polyurethane hydrogel drug reservoirs for use in transdermal drug delivery systems, and associated methods of manufacture and use |
| JP3081531B2 (ja) | 1996-03-22 | 2000-08-28 | 株式会社ヱビス科学研究所 | 手投げ消火液弾 |
| US5762956A (en) | 1996-04-24 | 1998-06-09 | Rutgers, The State University Of New Jersey | Transdermal contraceptive delivery system and process |
| IT1283102B1 (it) | 1996-06-06 | 1998-04-07 | Permatec Nv | Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele |
| RU2122396C1 (ru) | 1996-07-12 | 1998-11-27 | Валентина Александровна Андрюшина | Биологически-активная добавка в косметические изделия |
| KR20000035801A (ko) | 1996-10-30 | 2000-06-26 | 에버트 챨스 디 | 침투증강제로써라틱산지방산에스테르염 |
| KR100215027B1 (ko) | 1997-01-27 | 1999-08-16 | 성재갑 | 스테로이드계 약물의 경피흡수투여용 조성물 및 이를 포함하는 경피흡수투여용 제형 |
| JP4139860B2 (ja) | 1997-11-10 | 2008-08-27 | ストラカン インターナショナル リミティッド | 浸透増強および刺激減少システム |
| EP1043020A1 (en) | 1997-12-25 | 2000-10-11 | Daiichi Pharmaceutical Co., Ltd. | Medicinal composition for percutaneous administration |
| US6582724B2 (en) | 1999-12-16 | 2003-06-24 | Dermatrends, Inc. | Dual enhancer composition for topical and transdermal drug delivery |
| AU2001282064B2 (en) | 2000-08-03 | 2007-02-01 | Antares Pharma Ipl Ag | Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels |
| KR100416646B1 (ko) | 2000-08-14 | 2004-02-05 | 구주제약주식회사 | 리도카인을 함유한 조루치료용 마이크로에멀젼 하이드로겔 제형의 약학 조성물 |
| US20040002482A1 (en) | 2000-08-30 | 2004-01-01 | Dudley Robert E. | Androgen pharmaceutical composition and method for treating depression |
| US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
| FR2814074B1 (fr) | 2000-09-15 | 2003-03-07 | Theramex | Nouvelles compositions estro-progestatives topiques a effet systemique |
| JP2002212105A (ja) | 2001-01-22 | 2002-07-31 | Lion Corp | 水性皮膚外用剤組成物 |
| AU2002340120A1 (en) | 2001-10-04 | 2003-04-14 | Cellegy Pharmaceuticals, Inc. | Semisolid topical hormonal compositions and methods for treatment |
| US20040072810A1 (en) | 2001-11-07 | 2004-04-15 | Besins International Belgique | Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof |
| WO2004091631A1 (en) * | 2002-03-15 | 2004-10-28 | Unimed Pharmaceuticals, Inc. | Androgen pharmaceutical composition and method for treating depression |
| US6756050B2 (en) | 2002-06-28 | 2004-06-29 | Ultra Biotech Limited | Dietary supplements for improving memory |
| FR2848112B1 (fr) | 2002-12-10 | 2007-02-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse comprenant au moins un progestatif et/ou au moins un oestrogene, son procede de preparation et ses utilisations |
| FR2851470B1 (fr) | 2003-02-20 | 2007-11-16 | Besins Int Belgique | Composition pharmaceutique pour administration transdermique ou transmuqueuse |
| EP1952810B1 (en) | 2003-04-01 | 2014-01-08 | Besins Healthcare Luxembourg SARL | Treatment of breast cancer with 4-hydroxytamoxifen |
| US20070196325A1 (en) | 2004-06-07 | 2007-08-23 | Jie Zhang | Compositions and methods for dermally treating infections |
| EP1634583A1 (en) | 2004-09-09 | 2006-03-15 | Laboratoires Besins International | Testosterone gels comprising propylene glycol as penetration enhancer |
| EP1799201B1 (en) * | 2004-10-14 | 2008-11-26 | Laboratoires Besins International | 4-hydroxy tamoxifen gel formulations |
| EP1647271A1 (en) | 2004-10-14 | 2006-04-19 | Laboratoires Besins International | 4-Hydroxy tamoxifen gel formulations |
| US20070082039A1 (en) | 2004-10-18 | 2007-04-12 | Jones Gerald S Jr | Synthesis of fatty alcohol esters of alpha-hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers, and topical gels for the transdermal delivery of steroids |
| CN101217874B (zh) | 2005-04-12 | 2012-06-06 | 优尼麦德药物股份有限公司 | 治疗或预防骨退化或骨质疏松症的方法 |
| AU2006241285B2 (en) | 2005-04-25 | 2011-04-14 | Dermalogix Partners, Inc. | Use of a clobetasol spray formulation to treat psoriasis |
| WO2007038496A2 (en) * | 2005-09-27 | 2007-04-05 | Chemic Laboratories, Inc. | Synthesis of fatty alcohol esters of hydroxy carboxylic acids, the use of the same as percutaneous permeation enhancers |
| EP2147674A1 (en) | 2008-07-24 | 2010-01-27 | Besins Healthcare | Transdermal pharmaceutical compositions comprising danazol |
| SI3202420T1 (sl) | 2008-12-11 | 2020-08-31 | Besins Healthcare Luxembourg Sarl | Transdermalni farmacevtski sestavki, ki obsegajo serm |
| US10080760B2 (en) | 2009-10-27 | 2018-09-25 | Besins Healthcare Luxembourg Sarl | Transdermal pharmaceutical compositions comprising active agents |
-
2010
- 2010-10-26 US US12/912,310 patent/US10080760B2/en active Active
- 2010-10-27 HU HUE18163659A patent/HUE062026T2/hu unknown
- 2010-10-27 PT PT181636598T patent/PT3360575T/pt unknown
- 2010-10-27 BR BR112012010083A patent/BR112012010083B8/pt active IP Right Grant
- 2010-10-27 EP EP10768983.8A patent/EP2493508B1/en active Active
- 2010-10-27 PL PL10768983T patent/PL2493508T3/pl unknown
- 2010-10-27 DK DK18163659.8T patent/DK3360575T3/da active
- 2010-10-27 SI SI201031737T patent/SI2493508T1/sl unknown
- 2010-10-27 LT LTEP18163659.8T patent/LT3360575T/lt unknown
- 2010-10-27 SI SI201032129T patent/SI3360575T1/sl unknown
- 2010-10-27 HU HUE10768983A patent/HUE039200T2/hu unknown
- 2010-10-27 ES ES10768983.8T patent/ES2685313T3/es active Active
- 2010-10-27 FI FIEP18163659.8T patent/FI3360575T3/fi active
- 2010-10-27 RS RS20180963A patent/RS57596B1/sr unknown
- 2010-10-27 JP JP2012535814A patent/JP5727494B2/ja active Active
- 2010-10-27 LT LTEP10768983.8T patent/LT2493508T/lt unknown
- 2010-10-27 EP EP18163659.8A patent/EP3360575B1/en active Active
- 2010-10-27 RU RU2012121708A patent/RU2639087C2/ru active
- 2010-10-27 RU RU2017131709A patent/RU2017131709A/ru unknown
- 2010-10-27 HR HRP20230482TT patent/HRP20230482T1/hr unknown
- 2010-10-27 DK DK10768983.8T patent/DK2493508T3/en active
- 2010-10-27 CA CA2778689A patent/CA2778689C/en active Active
- 2010-10-27 AU AU2010311523A patent/AU2010311523B2/en active Active
- 2010-10-27 TR TR2018/11600T patent/TR201811600T4/tr unknown
- 2010-10-27 PL PL18163659.8T patent/PL3360575T3/pl unknown
- 2010-10-27 CN CN201080059696.5A patent/CN102686240B/zh active Active
- 2010-10-27 RS RS20230352A patent/RS64190B1/sr unknown
- 2010-10-27 WO PCT/EP2010/066283 patent/WO2011051354A2/en active Application Filing
- 2010-10-27 ES ES18163659T patent/ES2945590T3/es active Active
- 2010-10-27 PT PT10768983T patent/PT2493508T/pt unknown
-
2012
- 2012-04-17 IL IL219236A patent/IL219236A/en active IP Right Grant
- 2012-04-18 ZA ZA2012/02855A patent/ZA201202855B/en unknown
-
2018
- 2018-08-13 CY CY181100850T patent/CY1120888T1/el unknown
- 2018-08-23 HR HRP20181346TT patent/HRP20181346T1/hr unknown
- 2018-08-23 US US16/111,098 patent/US11040043B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181346T1 (hr) | Transdermalni farmaceutski pripravci koji sadrže aktivne tvari | |
| HRP20180924T1 (hr) | Sastavi za transdermalnu administraciju aktivnih sastojaka | |
| HK1169960A1 (en) | Pharmaceutical formulation | |
| HU0900072D0 (en) | Transdermal pharmaceutical compositions | |
| HK1199217A1 (en) | Topical pharmaceutical composition including active agents | |
| EP2468771A4 (en) | PHARMACEUTICAL COMPOSITION WITH AN ANTIBODY TO HB-EGF AS AN ACTIVE SUBSTANCE | |
| EP2465512A4 (en) | PHARMACEUTICAL COMPOSITION FOR PREVENTING PAIN | |
| GB0902648D0 (en) | Pharmaceutical compounds and compositions | |
| GB0908317D0 (en) | Pharmaceutical compounds and compositions | |
| EP2514440A4 (en) | TRANSDERMAL PREPARATION WITH A BASIC INFLAMMATORY MEDIUM | |
| IL226237A0 (en) | Pharmaceutical preparations for administration through the skin | |
| GB0903945D0 (en) | Pharmaceutical compounds and compositions | |
| GB0919055D0 (en) | Pharmaceutical compounds and compositions | |
| GB0908069D0 (en) | Pharmaceutical compounds and compositions | |
| GB0902651D0 (en) | Pharmaceutical compounds and compositions | |
| GB0905555D0 (en) | Pharmaceutical agent | |
| GB0910754D0 (en) | Pharmaceutical agent | |
| GB0905557D0 (en) | Pharmaceutical agent | |
| GB0905558D0 (en) | Pharmaceutical agent | |
| GB0913956D0 (en) | Pharmaceutical agent | |
| GB0920790D0 (en) | Pharmaceutical agent | |
| GB0918912D0 (en) | Improved medicament formulation |